Status:
COMPLETED
Monitoring of Breast Tissue Change Due to Hormone Replacement Therapy in Post-menopausal Women Using OBS
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Unity Health Toronto
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-65 years
Brief Summary
Hormone Replacement Therapy (HRT) is a double edged sword: it can alleviate the effects of menopause for a significant proportion of the female population, however for a smaller proportion, it will in...
Detailed Description
Hormone Replacement Therapy (HRT) provides many benefits to post-menopausal women, which have been overshadowed by an increase in breast cancer in women following HRT, resulting in a negative HRT cost...
Eligibility Criteria
Inclusion
- Cases
- Post-menopausal
- Attending the Endocrinology clinic at SMH
- Will start HRT treatment
Exclusion
- Current or Past HRT treatment
- Prior breast cancer
- Benign breast disease
- Bilateral breast biopsy
- Fine needle aspiration (FNA) within a year
- Cosmetic alteration (reduction/augmentation)
- Gynecological surgery
- Past or current chemo- therapeutic or prevention treatment
- Controls
- Inclusion Criteria:
- Not on HRT treatment
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00797199
Start Date
September 1 2011
End Date
January 1 2015
Last Update
March 23 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9
2
St. Michael's Hospital
Toronto, Ontario, Canada